Cpx (DrugBank: -)
2 diseases| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 215 | Tetralogy of Fallot | 1 |
| 299 | Cystic fibrosis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03835494 (ClinicalTrials.gov) | November 1, 2018 | 8/1/2019 | Analysis of RV-Dysfunction in Fallot Patients | Tissue Doppler Imaging - A Promising Technique To Assess Myocardial Function In Adult Fallot Patients | Tetralogy of Fallot | Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings. | Klinik für Kardiologie, Pneumologie und Angiologie | NULL | Completed | 18 Years | 80 Years | All | 60 | N/A | Germany |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004428 (ClinicalTrials.gov) | September 1997 | 18/10/1999 | Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis | Cystic Fibrosis | Drug: CPX | FDA Office of Orphan Products Development | SciClone Pharmaceuticals | Completed | 18 Years | N/A | Both | 35 | Phase 1 | NULL |